Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax

Vaccine

Volumn 29, Issue 26, 2011, Pages 4308-4315

  Doi, Masanori ^a   Tanabe, Kazuyuki ^b   Tachibana, Shin Ichiro ^b   Hamai, Meiko ^c   Tachibana, Mayumi ^c   Mita, Toshihiro ^d   Yagi, Masanori ^b   Zeyrek, Fadile Yildiz ^e   Ferreira, Marcelo U ^f   Ohmae, Hiroshi ^g   Kaneko, Akira ^h,i   Randrianarivelojosia, Milijaona ^j   Sattabongkot, Jetsumon ^k   Cao, Ya Ming ^l   Horii, Toshihiro ^b   Torii, Motomi ^a,c   Tsuboi, Takafumi ^a  

^a EHIME UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e HARRAN UNIVERSITY   (Turkey)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ NAGASAKI UNIVERSITY   (Japan)

^j INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^k ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^l CHINA MEDICAL UNIVERSITY   (China)

more..

Author keywords

Gametocyte surface antigen; Malaria; Plasmodium vivax; Purifying selection; Pvs230; Transmission blocking vaccine

Indexed keywords

CYSTEINE; MALARIA VACCINE; MEMBRANE PROTEIN; NUCLEOTIDE; OLIGOPEPTIDE; PVS 230; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; GENETIC CONSERVATION; GENETIC POLYMORPHISM; HUMAN; INTERSPECIFIC RELATIONSHIP; NEUROMUSCULAR BLOCKING; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PARASITE; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; CONSERVED SEQUENCE; DNA, PROTOZOAN; HUMANS; MALARIA VACCINES; MALARIA, VIVAX; MOLECULAR SEQUENCE DATA; PHYLOGENY; PLASMODIUM VIVAX; PROTOZOAN PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA;

EID: 79957862522     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.04.028     Document Type: Article

References (73)

1. WHO. World Malaria Report 2009. Geneva, Switzerland: WHO Press; 2009.
2. Price R.N., Tjitra E., Guerra C.A., Yeung S., White N.J., Anstey N.M. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 2007, 77:79-87.
3. Mueller I., Galinski M.R., Baird J.K., Carlton J.M., Kochar D.K., Alonso P.L., et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 2009, 9:555-566.
4. Arevalo-Herrera M., Chitnis C., Herrera S. Current status of Plasmodium vivax vaccine. Hum Vaccine 2010, 6:124-132.
5. Carter R., Mendis K.N., Miller L.H., Molineaux L., Saul A. Malaria transmission-blocking vaccines-how can their development be supported?. Nat Med 2000, 6:241-244.
6. Kaslow D.C., Quakyi I.A., Syin C., Raum M.G., Keister D.B., Coligan J.E., et al. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature 1988, 333:74-76.
7. Wu Y., Przysiecki C., Flanagan E., Bello-Irizarry S.N., Ionescu R., Muratova O., et al. Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex. Proc Natl Acad Sci USA 2006, 103:18243-18248.
8. Hisaeda H., Stowers A.W., Tsuboi T., Collins W.E., Sattabongkot J., Suwanabun N., et al. Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes. Infect Immun 2000, 68:6618-6623.
9. Kaslow D.C. Transmission-blocking vaccines. Chem Immunol 2002, 80:287-307.
10. Malkin E.M., Durbin A.P., Diemert D.J., Sattabongkot J., Wu Y., Miura K., et al. Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. Vaccine 2005, 23:3131-3138.
11. Wu Y., Ellis R.D., Shaffer D., Fontes E., Malkin E.M., Mahanty S., et al. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. PLoS One 2008, 3:e2636.
12. Tsuboi T., Tachibana M., Kaneko O., Torii M. Transmission-blocking vaccine of vivax malaria. Parasitol Int 2003, 52:1-11.
13. Templeton T.J., Kaslow D.C. Identification of additional members define a Plasmodium falciparum gene superfamily which includes Pfs48/45 and Pfs230. Mol Biochem Parasitol 1999, 101:223-227.
14. Kocken C.H., Jansen J., Kaan A.M., Beckers P.J., Ponnudurai T., Kaslow D.C., et al. Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum. Mol Biochem Parasitol 1993, 61:59-68.
15. van Dijk M.R., Janse C.J., Thompson J., Waters A.P., Braks J.A., Dodemont H.J., et al. A central role for P48/45 in malaria parasite male gamete fertility. Cell 2001, 104:153-164.
16. Carter R., Coulson A., Bhatti S., Taylor B.J., Elliott J.F. Predicted disulfide-bonded structures for three uniquely related proteins of Plasmodium falciparum, Pfs230, Pfs48/45 and Pf12. Mol Biochem Parasitol 1995, 71:203-210.
17. Gerloff D.L., Creasey A., Maslau S., Carter R. Structural models for the protein family characterized by gamete surface protein Pfs230 of Plasmodium falciparum. Proc Natl Acad Sci USA 2005, 102:13598-13603.
18. Williamson K.C., Criscio M.D., Kaslow D.C. Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230. Mol Biochem Parasitol 1993, 58:355-358.
19. van Dijk M.R., van Schaijk B.C., Khan S.M., van Dooren M.W., Ramesar J., Kaczanowski S., et al. Three members of the 6-cys protein family of Plasmodium play a role in gamete fertility. PLoS Pathog 2010, 6:e1000853.
20. Eksi S., Czesny B., van Gemert G.J., Sauerwein R.W., Eling W., Williamson K.C. Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production. Mol Microbiol 2006, 61:991-998.
21. Rener J., Graves P.M., Carter R., Williams J.L., Burkot T.R. Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum. J Exp Med 1983, 158:976-981.
22. Vermeulen A.N., Ponnudurai T., Beckers P.J., Verhave J.P., Smits M.A., Meuwissen J.H. Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito. J Exp Med 1985, 162:1460-1476.
23. Carter R., Graves P.M., Keister D.B., Quakyi I.A. Properties of epitopes of Pfs48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of Plasmodium falciparum. Parasite Immunol 1990, 12:587-603.
24. Read D., Lensen A.H., Begarnie S., Haley S., Raza A., Carter R. Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing. Parasite Immunol 1994, 16:511-519.
25. Quakyi I.A., Carter R., Rener J., Kumar N., Good M.F., Miller L.H. The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. J Immunol 1987, 139:4213-4217.
26. Williamson K.C., Keister D.B., Muratova O., Kaslow D.C. Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes. Mol Biochem Parasitol 1995, 75:33-42.
27. Healer J., McGuinness D., Carter R., Riley E. Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230. Parasitology 1999, 119:425-433.
28. Graves P.M., Carter R., Burkot T.R., Quakyi I.A., Kumar N. Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera. Parasite Immunol 1988, 10:209-218.
29. Hughes M.K., Hughes A.L. Natural selection on Plasmodium surface proteins. Mol Biochem Parasitol 1995, 71:99-113.
30. Healer J., Murphy V., Hodder A.N., Masciantonio R., Gemmill A.W., Anders R.F., et al. Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum. Mol Microbiol 2004, 52:159-168.
31. Martinelli A., Cheesman S., Hunt P., Culleton R., Raza A., Mackinnon M., et al. A genetic approach to the de novo identification of targets of strain-specific immunity in malaria parasites. Proc Natl Acad Sci USA 2005, 102:814-819.
32. Richards J.S., MacDonald N.J., Eisen D.P. Limited polymorphism in Plasmodium falciparum ookinete surface antigen, von Willebrand factor A domain-related protein from clinical isolates. Malar J 2006, 5:55.
33. Niederwieser I., Felger I., Beck H.P. Limited polymorphism in Plasmodium falciparum sexual-stage antigens. Am J Trop Med Hyg 2001, 649-711.
34. Williamson K.C., Kaslow D.C. Strain polymorphism of Plasmodium falciparum transmission-blocking target antigen Pfs230. Mol Biochem Parasitol 1993, 62:125-127.
35. Tsuboi T., Kaslow D.C., Gozar M.M., Tachibana M., Cao Y.M., Torii M. Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates. Mol Med 1998, 4:772-782.
36. Zakeri S., Razavi S., Djadid N.D. Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran. Acta Trop 2009, 109:176-180.
37. Carlton J.M., Adams J.H., Silva J.C., Bidwell S.L., Lorenzi H., Caler E., et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 2008, 455:757-763.
38. Ferreira M.U., Karunaweera N.D., da Silva-Nunes M., da Silva N.S., Wirth D.F., Hartl D.L. Population structure and transmission dynamics of Plasmodium vivax in rural Amazonia. J Infect Dis 2007, 195:1218-1226.
39. Orjuela-Sanchez P., da Silva N.S., da Silva-Nunes M., Ferreira M.U. Recurrent parasitemias and population dynamics of Plasmodium vivax polymorphisms in rural Amazonia. Am J Trop Med Hyg 2009, 81:961-968.
40. Zeyrek F.Y., Babaoglu A., Demirel S., Erdogan D.D., Ak M., Korkmaz M., et al. Analysis of naturally acquired antibody responses to the 19-kd C-terminal region of merozoite surface protein-1 of Plasmodium vivax from individuals in Sanliurfa, Turkey. Am J Trop Med Hyg 2008, 78:729-732.
41. Tanabe K., Mita T., Jombart T., Eriksson A., Horibe S., Palacpac N., et al. Plasmodium falciparum accompanied the human expansion out of Africa. Curr Biol 2010, 20:1283-1289.
42. Yamauchi T., Nakazawa M., Ohmae H., Kamei K., Sato K., Bakote'e B. Impact of ethnic conflict on the nutritional status and quality of life of suburban villagers in the Solomon Islands. J Nutri Sci Vitaminol 2010, 56:227-234.
43. Tanabe K., Escalante A., Sakihama N., Honda M., Arisue N., Horii T., et al. Recent independent evolution of msp1 polymorphism in Plasmodium vivax and related simian malaria parasites. Mol Biochem Parasitol 2007, 156:74-79.
44. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL.W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680.
45. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24:1596-1599.
46. Saitou N., Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987, 4:406-425.
47. Rozas J., Sanchez-DelBarrio J.C., Messeguer X., Rozas R. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 2003, 19:2496-2497.
48. Wright S. The interpretation of population structure by F-statistics with special regard to systems of mating. Evolution 1965, 19:395-420.
49. Excoffier L., Smouse P.E., Quattro J.M. Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics 1992, 131:479-491.
50. Nei M., Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 1986, 3:418-426.
51. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 1989, 123:585-595.
52. Fu Y.X., Li W.H. Statistical tests of neutrality of mutations. Genetics 1993, 133:693-709.
53. McDonald J.H., Kreitman M. Adaptive protein evolution at the Adh locus in Drosophila. Nature 1991, 351:652-654.
54. Nachman M.W., Brown W.M., Stoneking M., Aquadro C.F. Nonneutral mitochondrial DNA variation in humans and chimpanzees. Genetics 1996, 142:953-963.
55. Tetteh K.K., Stewart L.B., Ochola L.I., Amambua-Ngwa A., Thomas A.W., Marsh K., et al. Prospective identification of malaria parasite genes under balancing selection. PLoS One 2009, 4:e5568.
56. Brooks S.R., Williamson K.C. Proteolysis of Plasmodium falciparum surface antigen, Pfs230, during gametogenesis. Mol Biochem Parasitol 2000, 106:77-82.
57. Riley E.M., Williamson K.C., Greenwood B.M., Kaslow D.C. Human immune recognition of recombinant proteins representing discrete domains of the Plasmodium falciparum gamete surface protein, Pfs230. Parasite Immunol 1995, 17:11-19.
58. Sanders P.R., Gilson P.R., Cantin G.T., Greenbaum D.C., Nebl T., Carucci D.J., et al. Distinct protein classes including novel merozoite surface antigens in Raft-like membranes of Plasmodium falciparum. J Biol Chem 2005, 280:40169-40176.
59. Ishino T., Chinzei Y., Yuda M. Two proteins with 6-cys motifs are required for malarial parasites to commit to infection of the hepatocyte. Mol Microbiol 2005, 58:1264-1275.
60. Escalante A.A., Freeland D.E., Collins W.E., Lal A.A. The evolution of primate malaria parasites based on the gene encoding cytochrome b from the linear mitochondrial genome. Proc Natl Acad Sci USA 1998, 95:8124-8129.
61. Hayakawa T., Culleton R., Otani H., Horii T., Tanabe K. Big bang in the evolution of extant malaria parasites. Mol Biol Evol 2008, 25:2233-2239.
62. Mitsui H., Arisue N., Sakihama N., Inagaki Y., Horii T., Hasegawa M., et al. Phylogeny of Asian primate malaria parasites inferred from apicoplast genome-encoded genes with special emphasis on the positions of Plasmodium vivax and P. fragile. Gene 2010, 450:32-38.
63. Sawai H., Otani H., Arisue N., Palacpac N., de Oliveira Martins L., Pathirana S., et al. Lineage-specific positive selection at the merozoite surface protein 1 (msp1) locus of Plasmodium vivax and related simian malaria parasites. BMC Evol Biol 2010, 10:52.
64. Ord R., Polley S., Tami A., Sutherland C.J. High sequence diversity and evidence of balancing selection in the Pvmsp3alpha gene of Plasmodium vivax in the Venezuelan Amazon. Mol Biochem Parasitol 2005, 144:86-93.
65. Rayner J.C., Huber C.S., Feldman D., Ingravallo P., Galinski M.R., Barnwell J.W. Plasmodium vivax merozoite surface protein PvMSP-3 beta is radically polymorphic through mutation and large insertions and deletions. Infect Genet Evol 2004, 4:309-319.
66. Gomez A., Suarez C.F., Martinez P., Saravia C., Patarroyo M.A. High polymorphism in Plasmodium vivax merozoite surface protein-5 (MSP5). Parasitology 2006, 133:661-672.
67. Putaporntip C., Udomsangpetch R., Pattanawong U., Cui L., Jongwutiwes S. Genetic diversity of the Plasmodium vivax merozoite surface protein-5 locus from diverse geographic origins. Gene 2010, 456:24-35.
68. Martinez P., Suarez C.F., Cardenas P.P., Patarroyo M.A. Plasmodium vivax Duffy binding protein: a modular evolutionary proposal. Parasitology 2004, 128:353-366.
69. Palumbi S.R. Speciation and the evolution of gamete recognition genes: pattern and process. Heredity 2009, 102:66-76.
70. Tsaur S.C., Ting C.T., Wu C.I. Sex in Drosophila mauritiana: a very high level of amino acid polymorphism in a male reproductive protein gene, Acp26Aa. Mol Biol Evol 2001, 18:22-26.
71. Conway D.J., Machado R.L., Singh B., Dessert P., Mikes Z.S., Povoa M.M., et al. Extreme geographical fixation of variation in the Plasmodium falciparum gamete surface protein gene Pfs48/45 compared with microsatellite loci. Mol Biochem Parasitol 2001, 115:145-156.
72. Imwong M., Nair S., Pukrittayakamee S., Sudimack D., Williams J.T., Mayxay M., et al. Contrasting genetic structure in Plasmodium vivax populations from Asia and South America. Int J Parasitol 2007, 37:1013-1022.
73. Orjuela-Sanchez P., Karunaweera N.D., da Silva-Nunes M., da Silva N.S., Scopel K.K., Goncalves R.M., et al. Single-nucleotide polymorphism, linkage disequilibrium and geographic structure in the malaria parasite Plasmodium vivax: prospects for genome-wide association studies. BMC Genet 2010, 11:65.